safety concerns with inhaled long-acting beta-agonists (Serevent, etc) for asthma

Please see the FDA's new recommendations for the use of long-acting beta agonists

You'll hear more about safety concerns with inhaled long-acting beta-agonists (Serevent, etc) for asthma.

There are already warnings about a possible increased risk of severe asthma attacks and death.

This is seen when inhaled long-acting beta-agonists are used ALONE for asthma...instead of with an inhaled corticosteroid.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote